Yu Cheng

9PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Computational physiologyAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 03, 2026
Post-marketing safety monitoring of sodium-glucose cotransporter 2 inhibitors for diabetes in cats: a pharmacovigilance study based on the FDA ADAE database.

|Aug 25, 2026
The Role of IGF2BP3-Mediated Immune Response Activation in Enhancing Immunotherapy of Koumine for Gastric Cancer.

|May 22, 2026
A Mechanistic Framework Integrating Renal QSP-PK-PD and Machine Learning for Baseline-Informed Stratification of Diuretic Resistance.

|Dec 11, 2025
Disproportionality analysis of adverse events associated with bimekizumab: a real-world study based on FDA Adverse Event Reporting System (FAERS) Database.

Xiaojuan Lin, Liwei Guo, Tian Lin

|Apr 16, 2025
Population pharmacokinetics study on nebulized and intravenous administration of polymyxin B in patients with pneumonia caused by multidrug-resistant gram-negative bacteria.

Xueyong Li, Lili Zhou, Danjie Wang

|Mar 18, 2024
Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review.

Yu Cheng, Yujia Zhang, Ying Zhang

Pageof 2

Frequent Collaborators

2 joint publications

Hongqiang Qiu

2 joint publications

Maohua Chen

1 joint publications

Zheng Jiao

1 joint publications

Limei Zhao